Flow cytometry analysis also demonstrated that the ratio of LAMP3+DCs in neoadjuvant MPR tumor lesions was significantly higher than that in treatment-naive tumor tissues, and displayed an increasing trend in MPR than non-MPR tumor tissues (Fig. 6E). The gene discussed is LAMP3; the disease is neoplasm.